SOUTH PLAINFIELD, N.J. (AP) — SOUTH PLAINFIELD, N.J. (AP) — PTC Therapeutics Inc. (PTCT) on Thursday reported a loss of $155.8 million in its fourth quarter.
The South Plainfield, New Jersey-based company said it had a loss of $2.06 per share. Losses, adjusted to extinguish debt, came to 24 cents per share.
The results missed Wall Street expectations. The average estimate of eight analysts surveyed by Zacks Investment Research was for earnings of 29 cents per share.
The biopharmaceutical company posted revenue of $307.1 million in the period, which also did not meet Street forecasts. Five analysts surveyed by Zacks expected $315.9 million.
For the year, the company reported a loss of $626.6 million, or $8.37 per share. Revenue was reported as $937.8 million.
PTC Therapeutics expects full-year revenue in the range of $600 million to $680 million.
_____
This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on PTCT at https://www.zacks.com/ap/PTCT